Dr. Reddy's Laboratories Limited (RDDA) — Free Cash Flow Generation Index
Dr. Reddy's Laboratories Limited (RDDA) has a Free Cash Flow Generation Index of 0.33x as of December 2025. Free cash flow of €3.59 Billion represents 0% of operating cash flow (€10.91 Billion). Read debt load of Dr. Reddy's Laboratories Limited for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Dr. Reddy's Laboratories Limited Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Dr. Reddy's Laboratories Limited across 9 annual periods. Explore how much does Dr. Reddy's Laboratories Limited reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year Free Cash Flow Generation Index for Dr. Reddy's Laboratories Limited. For the full company profile including market capitalisation, see Dr. Reddy's Laboratories Limited market capitalisation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | €12.03 Billion | €46.43 Billion | €34.40 Billion | ▼ -34.6% |
| 2024 | 0.40x | €18.00 Billion | €45.43 Billion | €27.43 Billion | ▼ -41.7% |
| 2023 | 0.68x | €40.01 Billion | €58.88 Billion | €18.87 Billion | ▲ +110.9% |
| 2022 | 0.32x | €9.06 Billion | €28.11 Billion | €14.66 Billion | ▼ -50.3% |
| 2021 | 0.65x | €23.14 Billion | €35.70 Billion | €9.74 Billion | ▼ -18.5% |
| 2020 | 0.80x | €23.73 Billion | €29.84 Billion | €4.85 Billion | ▲ +7.6% |
| 2019 | 0.74x | €21.21 Billion | €28.70 Billion | €6.96 Billion | ▲ +90.7% |
| 2018 | 0.39x | €6.99 Billion | €18.03 Billion | €9.29 Billion | ▼ -75.3% |
| 2017 | 1.57x | €33.79 Billion | €21.51 Billion | €12.28 Billion | — |